Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAIDs vs. Coxibs in the Presence of Aspirin in Rheumatoid Arthritis With Cardiovascular Risk
NCT03699293Phase 4Terminated
- Sponsor
- Platelet and Thrombosis Research
- Start
- Sep 2018
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of celecoxib oral solution and Aprol in rheumatoid arthritis (RA) (2 arms), sponsored by Platelet and Thrombosis Research. Primary endpoints: Change in Arachidonic Acid (AA)-Induced Platelet Aggregation at 12 weeks, Change in Collagen-induced Platelet Aggregation at 12 weeks and 2 more. Started Sep 2018; status: terminated.
02
Drugs
celecoxib oral solutionAprol
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03699293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03699293.